InvestorsObserver
×
News Home

Is Aridis Pharmaceuticals Inc (ARDS) a Stock to Watch After Gaining 6.00% This Week?

Monday, July 26, 2021 09:53 AM | InvestorsObserver Analysts

Mentioned in this article

Is Aridis Pharmaceuticals Inc (ARDS) a Stock to Watch After Gaining 6.00% This Week?

Aridis Pharmaceuticals Inc (ARDS) stock is higher by 6.00% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bearish
Aridis Pharmaceuticals Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ARDS!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With ARDS Stock Today?

Aridis Pharmaceuticals Inc (ARDS) stock is up 2.51% while the S&P 500 is down -0.03% as of 9:49 AM on Monday, Jul 26. ARDS has gained $0.13 from the previous closing price of $5.17 on volume of 80,500 shares. Over the past year the S&P 500 is higher by 36.15% while ARDS is down -22.97%. ARDS lost -$2.48 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Aridis Pharmaceuticals Inc click here.

More About Aridis Pharmaceuticals Inc

Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Click Here to get the full Stock Report for Aridis Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App